200 related articles for article (PubMed ID: 24924305)
21. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
[TBL] [Abstract][Full Text] [Related]
22. Antifungal activity of Punicalagin-nystatin combinations against Candida albicans.
da Silva RA; Ishikiriama BLC; Ribeiro Lopes MM; de Castro RD; Garcia CR; Porto VC; Santos CF; Neppelenbroek KH; Lara VS
Oral Dis; 2020 Nov; 26(8):1810-1819. PubMed ID: 32583467
[TBL] [Abstract][Full Text] [Related]
23. The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans.
Ellepola AN; Samaranayake LP
J Oral Pathol Med; 1998 May; 27(5):213-9. PubMed ID: 9682984
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of activity and toxicity of Nystatin-Intralipid.
Semis R; Kagan S; Berdicevsky I; Polacheck I; Segal E
Med Mycol; 2013 May; 51(4):422-31. PubMed ID: 23088298
[TBL] [Abstract][Full Text] [Related]
25. Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans.
Ellepola AN; Khajah R; Jayatilake S; Samaranayake L; Sharma P; Khan Z
J Appl Oral Sci; 2015; 23(4):412-8. PubMed ID: 26398514
[TBL] [Abstract][Full Text] [Related]
26. Adhesion of oral Candida species to human buccal epithelial cells following brief exposure to nystatin.
Ellepola AN; Panagoda GJ; Samaranayake LP
Oral Microbiol Immunol; 1999 Dec; 14(6):358-63. PubMed ID: 10895691
[TBL] [Abstract][Full Text] [Related]
27. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
Choukri F; Benderdouche M; Sednaoui P
J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
[TBL] [Abstract][Full Text] [Related]
28. Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.
Shinde RB; Chauhan NM; Raut JS; Karuppayil SM
Ann Clin Microbiol Antimicrob; 2012 Oct; 11():27. PubMed ID: 23035934
[TBL] [Abstract][Full Text] [Related]
29. In vitro antifungal activity of two tissue conditioners combined with nystatin, miconazole and fluconazole against Candida albicans.
Chopde N; Pharande A; Khade MN; Khadtare YR; Shah SS; Apratim A
J Contemp Dent Pract; 2012 Sep; 13(5):695-8. PubMed ID: 23250177
[TBL] [Abstract][Full Text] [Related]
30. [Comparative analysis of in vitro antifungal activity and in vivo acute toxicity of the nystatin analogue S44HP produced via genetic engineering].
Treshchalin ID; Sletta H; Borgos SE; Pereverzeva EP; Voeĭkova TA; Ellingsen TE; Zotchev SB
Antibiot Khimioter; 2005; 50(7):18-22. PubMed ID: 16768209
[TBL] [Abstract][Full Text] [Related]
31. Stability and efficacy of combined nystatin and chlorhexidine against suspensions and biofilms of Candida albicans.
Scheibler E; da Silva RM; Leite CE; Campos MM; Figueiredo MA; Salum FG; Cherubini K
Arch Oral Biol; 2018 May; 89():70-76. PubMed ID: 29477025
[TBL] [Abstract][Full Text] [Related]
32. The in vitro post-antifungal effect of nystatin on Candida species of oral origin.
Ellepola AN; Samaranayake LP
J Oral Pathol Med; 1999 Mar; 28(3):112-6. PubMed ID: 10069538
[TBL] [Abstract][Full Text] [Related]
33. The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
Brenciaglia MI; Ghezzi MC; Cipriani P; Mancini C; Trancassini M
Chemioterapia; 1986 Jun; 5(3):200-3. PubMed ID: 3521918
[TBL] [Abstract][Full Text] [Related]
34. Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study.
de Castro RD; de Souza TM; Bezerra LM; Ferreira GL; Costa EM; Cavalcanti AL
BMC Complement Altern Med; 2015 Nov; 15():417. PubMed ID: 26601661
[TBL] [Abstract][Full Text] [Related]
35. The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion.
Ellepola AN; Samaranayake LP
Oral Dis; 1998 Dec; 4(4):260-7. PubMed ID: 10200705
[TBL] [Abstract][Full Text] [Related]
36. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
Anil S; Ellepola AN; Samaranayake LP
J Oral Pathol Med; 2001 Sep; 30(8):481-8. PubMed ID: 11545239
[TBL] [Abstract][Full Text] [Related]
37. Influence of antifungal polyenes on the adhesion of Candida albicans and Candida glabrata to human epithelial cells in vitro.
Dorocka-Bobkowska B; Konopka K; Düzgüneş N
Arch Oral Biol; 2003 Dec; 48(12):805-14. PubMed ID: 14596870
[TBL] [Abstract][Full Text] [Related]
38. Structure-antifungal activity relationships of polyene antibiotics of the amphotericin B group.
Tevyashova AN; Olsufyeva EN; Solovieva SE; Printsevskaya SS; Reznikova MI; Trenin AS; Galatenko OA; Treshalin ID; Pereverzeva ER; Mirchink EP; Isakova EB; Zotchev SB; Preobrazhenskaya MN
Antimicrob Agents Chemother; 2013 Aug; 57(8):3815-22. PubMed ID: 23716057
[TBL] [Abstract][Full Text] [Related]
39. In vivo and in vitro activity of a bis-arylidenecyclo-alkanone against fluconazole-susceptible and -resistant isolates of Candida albicans.
de Sá NP; de Paula LFJ; Lopes LFF; Cruz LIB; Matos TTS; Lino CI; de Oliveira RB; de Souza-Fagundes EM; Fuchs BB; Mylonakis E; Johann S
J Glob Antimicrob Resist; 2018 Sep; 14():287-293. PubMed ID: 29715565
[TBL] [Abstract][Full Text] [Related]
40. Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis.
Zhang X; Li T; Chen X; Wang S; Liu Z
BMC Microbiol; 2018 Oct; 18(1):166. PubMed ID: 30359236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
